Oxidative Medicine and Cellular Longevity / 2011 / Article / Tab 1

Research Article

Evaluation of Chromosomal Instability in Diabetic Rats Treated with Naringin

Table 1

DNA strand breaks in bone marrow of nondiabetic and diabetic rats 24 hours after the last treatment with the indicated doses of naringin (4 weeks exposures, spaced 24 hours apart) (mean ± SD).

Treatment groups (mg/kg)Tail length (μm)Tail DNA (%)Tail moment (arbitrary unit)Olive tail moment (arbitrary units)

Nondiabetic control14.0 ± 4.85.98 ± 1.151.96 ± 0.614.78 ± 1.23
Nondiabetic + naringin (25)12.6 ± 4.775.76 ± 1.522.12 ± 0.434.14 ± 0.56
Nondiabetic + naringin (50)11.8 ± 4.714.82 ± 1.761.98 ± 0.233.20 ± 0.73
Diabetes27.2 ± 4.91*14.2 ± 3.39*4.72 ± 0.54**9.44 ± 2.03*
Diabetes + naringin (25)18.6 ± 4.33a8.08 ± 1.54b2.98 ± 0.85a5.82 ± 1.27b
Diabetes + naringin (50)15.8 ± 3.96b6.97 ± 1.53b2.24 ± 0.7b4.32 ± 1.18b

and versus nondiabetic control (Kruskal-Wallis test followed by Dunn’s multiple comparisons test). a and b versus diabetes alone (Mann-Whitney U test).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.